Oppenheimer is biggest bull on Wall Street again, raising S&P 500 forecast back to 7,100

Oppenheimer has reinstated its S&P 500 year-end 2025 price target to 7,100, up from 5,950, positioning it as Wall Street's most bullish firm with an implied 11.1% upside from Friday's close. This upward revision stems from recent progress in U.S. trade negotiations, including announced deals with Japan and the EU, which the firm believes have removed a significant market uncertainty that previously led to a reduced forecast. The move aligns with recent market performance, as the S&P 500 has achieved multiple record closes, partly driven by these trade developments.

Analysis

Oppenheimer has reinstated its year-end 2025 S&P 500 price target to 7,100, a level previously retracted, positioning the firm as the most bullish on Wall Street with an implied 11.1% upside from the last market close. This revision is directly attributed to the mitigation of trade-related risks, following the announcement of new trade agreements between the U.S. and key partners, notably Japan and the European Union. According to the firm's chief investment strategist, John Stoltzfus, these deals have removed "an uncertainty that had weighed on our market outlook." The EU agreement imposes a 15% tariff on most goods but critically exempts key sectors such as aircraft, certain chemicals, and pharmaceuticals. This targeted policy development provides a specific catalyst for the forecast upgrade, which was previously lowered to 5,950 after President Trump's April 2 tariff announcements were perceived as overly aggressive. The firm's renewed optimism is underscored by strong market technicals, with the S&P 500 achieving its fifth consecutive record close and posting a year-to-date gain of over 8%, demonstrating that positive sentiment around trade is already being priced into equities.

Key Decisions for Investors

• Given Oppenheimer's high-conviction bullish forecast, investors may consider increasing exposure to broad U.S. market indices like the S&P 500, as resolved trade disputes could sustain the current market rally.
• It is prudent to evaluate overweighting sectors that benefit directly from the announced EU trade deal, specifically industries like aerospace and pharmaceuticals that have been explicitly exempted from the 15% tariffs.
• Investors should monitor the implementation of these trade agreements and the finalization of pending deals, as any breakdown in negotiations could reintroduce the tariff-related volatility that previously led to the firm's forecast reduction.